|
May 2
|
Are Options Traders Betting on a Big Move in Surmodics Stock?
|
|
May 1
|
SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts
|
|
Apr 30
|
SurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to Say
|
|
Apr 30
|
SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates
|
|
Apr 30
|
SurModics: Fiscal Q2 Earnings Snapshot
|
|
Apr 30
|
Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance
|
|
Apr 28
|
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
|
|
Mar 10
|
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics
|
|
Jan 3
|
SurModics (SRDX) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
|
Jan 3
|
Best Momentum Stocks to Buy for January 3rd
|
|
Oct 2
|
SRDX Stock Down Despite FDA Clearance for Pounce XL System
|
|
Oct 1
|
Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter
|
|
May 4
|
Surmodics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
|
|
May 3
|
Surmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up
|
|
May 2
|
Surmodics Inc (SRDX) Q2 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...
|
|
May 1
|
SurModics (SRDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
May 1
|
SurModics (SRDX) Q2 Earnings and Revenues Top Estimates
|
|
May 1
|
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
|
|
Apr 30
|
Can the 4 Medical Device Stocks Hit Targets This Earnings Season?
|
|
Apr 19
|
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
|